NCT00801372 Use of Existing Fibroblast Cells to Convert to Induced Pluripotent Stem Cells
| NCT ID | NCT00801372 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hadassah Medical Organization |
| Condition | Pregnant, Healthy Females |
| Study Type | OBSERVATIONAL |
| Enrollment | 1 participants |
| Start Date | 2008-11 |
| Primary Completion | 2030-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1 participants in total. It began in 2008-11 with a primary completion date of 2030-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Induced pluripotent stem cells potentially may be useful in the future as an unlimited source of cells for transplantation. The major goal of the project is to develop human iPS cells from existing lines of fibroblasts that were originally donated as clinical grade feeders for the development of clinical grade hESCs. The clinical grade feeders were developed from aborted fetuses, foreskin and umbilical cord.
Eligibility Criteria
Inclusion Criteria: * healthy, older than 18 Exclusion Criteria: * non healthy, younger than 18
Contact & Investigator
Benjamin E Reubinoff, MD PhD
PRINCIPAL INVESTIGATOR
Chairman of Department of Obstetrics & Gynecology/IVF, Hadassah Ein Kerem
Frequently Asked Questions
Who can join the NCT00801372 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Pregnant, Healthy Females. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT00801372 currently recruiting?
Yes, NCT00801372 is actively recruiting participants. Contact the research team at benjaminr@ekmd.huji.ac.il for enrollment information.
Where is the NCT00801372 trial being conducted?
This trial is being conducted at Jerusalem, Israel.
Who is sponsoring the NCT00801372 clinical trial?
NCT00801372 is sponsored by Hadassah Medical Organization. The principal investigator is Benjamin E Reubinoff, MD PhD at Chairman of Department of Obstetrics & Gynecology/IVF, Hadassah Ein Kerem. The trial plans to enroll 1 participants.